6 consecutive trading days of Hainan Shuangcheng Pharmaceuticals (002693.SZ): The valuation of the target company involved in the restructuring will be significantly lower than the previous financing valuation of 10 billion yuan.

Hainan Shuangcheng Pharmaceuticals (002693.SZ) announced that the company plans to purchase 100% of the shares of Ningbo Aura Semiconductor Co., Ltd. ("Target") from 25 trading partners through the issuance of shares and cash payment, and intends to issue shares to raise funds from up to 35 specific investors ("this transaction"). This transaction is expected to constitute a related party transaction and a significant asset restructuring. As of the disclosure date of the announcement, the audit and evaluation of the target assets have not been completed, and the specific transaction price of this transaction has not been determined. Given that the current semiconductor index (886063.WI) has significantly decreased from its 2021 peak, the global macroeconomic environment and semiconductor industry investment and financing environment have changed compared to 2021. Therefore, the valuation of the target company in this transaction will be significantly lower than the previous financing valuation of 10 billion yuan.